I recently decided to sell my Novo Nordisk shares - at a price of €45.91. In the meantime, I even made a profit of around 100% on the position, but in the end I took a loss on the shares. $NOVO B (-7,92 %)
The reason: a restructuring in the portfolio, which allowed me to offset losses against gains from other shares for tax purposes. This allowed me to clean up my portfolio structure and optimize my tax burden at the same time.
Sometimes a strategic sale is more valuable than stubbornly holding on to old positions.

